According to research by nova one advisor, the global cell and gene therapy market size was valued at $18.13 billion in 2023 ...

President Trump signed an executive order on the day of his inauguration that created doubts about the future of a program ...

CAR T-cell therapies have demonstrated efficacy in treating blood cancers but, so far, their safety and effectiveness in ...

Iran has succeeded in producing cell therapy products which have received the Food and Drug Administration's approval.

Gene therapies to treat rheumatoid arthritis have evolved slowly, but one is ready to move into human trials and an ...

Britain's National Health Service (NHS) will provide a cutting-edge gene therapy that aims to cure sickle cell disease, the ...

Solvias, a global provider of chemistry, manufacturing, and control (CMC) analytics and headquartered in Switzerland, ...

The FDA approved betibeglogene autotemcel (beti-cel; Zynteglo) for adult and pediatric patients with transfusion-dependent ...